Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies
about
Progression of cutaneous melanoma: implications for treatmentChemosaturation Percutaneous Hepatic Perfusion: A Systematic ReviewEmerging local ablation techniquesSafety and efficacy of chemosaturation in patients with primary and secondary liver tumors.Isolated hepatic perfusion for patients with liver metastases.Development and Validation of Endovascular Chemotherapy Filter Device for Removing High-Dose Doxorubicin: Preclinical StudyUnknown primary nasopharyngeal melanoma presenting as severe recurrent epistaxis and hearing loss following treatment and remission of metastatic disease: A case report and literature review.Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies.Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: a single institution experience.Combination therapy targeting the tumor microenvironment is effective in a model of human ocular melanomaTechnical considerations in percutaneous hepatic perfusion--a multi-center experienceRecent trends and future perspectives in isolated hepatic perfusion in the treatment of liver tumors.Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies.Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion.Isolated hepatic perfusion for metastatic melanoma.Regional therapy in metastatic melanoma: an update on minimally invasive intraarterial isolated limb infusion and percutaneous hepatic perfusion.Interventional treatment for unresectable hepatocellular carcinoma.Evidence-based integration of selective internal radiation therapy into the management of ocular melanoma liver metastases.Chemosaturation With Percutaneous Hepatic Perfusion in Unresectable Hepatic Metastases.The Effect of Perfusate Buffering on Toxicity and Response in Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases.Evaluation of Delcath Systems' Generation 2 (GEN 2) melphalan hemofiltration system in a porcine model of percutaneous hepatic perfusionHemodynamics in rat liver tumor model during retrograde-outflow isolated hepatic perfusion with aspiration from the portal vein: angiography and in vivo microscopy.Retrograde-outflow percutaneous isolated hepatic perfusion using cisplatin: A pilot study on pharmacokinetics and feasibility.Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion.Prospective Clinical and Pharmacological Evaluation of the Delcath System's Second-Generation (GEN2) Hemofiltration System in Patients Undergoing Percutaneous Hepatic Perfusion with MelphalanFuture perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012".Percutaneous hepatic perfusion with melphalan in uveal melanoma: A safe and effective treatment modality in an orphan disease.Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver.Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcoma.Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases
P2860
Q27001734-1980A0D9-73A7-40A4-BFC7-BE8AAF6A6C53Q28069495-342CE0CF-2150-4FC8-AAA4-2E6E39162B95Q30477025-4185EF5C-E452-4471-BA7E-B303BE45FB03Q33442862-EDBA4E61-A4F2-4D5D-8FF2-34F24B45AA28Q33937362-E29AB41A-E47D-4F93-B650-87BF34040045Q34981443-3547542F-99D7-492F-9609-B106AF7B935FQ35601740-4EDE395D-0A48-438F-AD83-B8553B3154AEQ35646297-3C9FD5F5-A5F2-4ABF-870D-76BC734C3160Q35854809-627B1231-FE08-4D32-94A6-B87F2198AA93Q35928569-4282A91C-3FA4-4982-9391-99B751C25D38Q36374590-CAA3D2A7-19A0-4AE6-B059-3C249A9EEC12Q36448687-66B5C75D-81D7-4A05-A48C-0ABD7A1E5515Q36874742-6D210858-CE87-4827-B4BF-4AE8EC947771Q37943015-D346BD81-6B75-4DBF-874C-F1B737EFEDA6Q38156115-2E330BCE-9A46-48C1-97F7-E2E6943F3A1BQ38245172-2BC87CF7-9070-44C6-82AC-84ACEE46696DQ38259537-8028C554-884C-401A-8D84-B370597D40BDQ38283689-0182D3D2-C213-48A0-B080-C38BDD71B6A7Q38971611-6A8D7ADA-5624-4E6B-83E1-B0742312CAEAQ39097860-BC9159D8-A56A-4A1A-8FA1-5E9FC0628466Q39692827-32BF7466-A21A-44F7-AACD-7EC2E23DD1D1Q40137378-1F9E47B9-5652-4760-A396-0180B5DFCF81Q40244441-A1B677DE-63AF-47C1-B876-B68DA2028262Q40251215-66015F13-00DE-4E85-964D-69438ACA9E6BQ41368436-BBC9752A-6899-455D-B90E-8F24AA25D294Q43127268-B468D63B-3E1B-4127-A97A-44123C3144A3Q47239043-9731C106-9BCB-4C59-B20B-E64CD1FE277CQ52982266-47B3563C-0810-46DD-B6C3-7981BD4B98D1Q53156651-01F32338-A06F-4B33-BEB2-860BD06CEA91Q57317466-D790064A-55B4-4748-B6C8-E51AFEED87E0
P2860
Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Phase I study of hepatic arter ...... esectable hepatic malignancies
@ast
Phase I study of hepatic arter ...... esectable hepatic malignancies
@en
Phase I study of hepatic arter ...... esectable hepatic malignancies
@nl
type
label
Phase I study of hepatic arter ...... esectable hepatic malignancies
@ast
Phase I study of hepatic arter ...... esectable hepatic malignancies
@en
Phase I study of hepatic arter ...... esectable hepatic malignancies
@nl
prefLabel
Phase I study of hepatic arter ...... esectable hepatic malignancies
@ast
Phase I study of hepatic arter ...... esectable hepatic malignancies
@en
Phase I study of hepatic arter ...... esectable hepatic malignancies
@nl
P2093
P2860
P356
P1476
Phase I study of hepatic arter ...... esectable hepatic malignancies
@en
P2093
Anthony W Kam
Geoffrey D Seidel
H Richard Alexander
James F Pingpank
Richard Chang
Souping Zhai
Steven K Libutti
Tatiana Beresneva
William D Figg
Ziv Neeman
P2860
P304
P356
10.1200/JCO.2005.00.927
P407
P577
2005-05-20T00:00:00Z